These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9686695)

  • 41. Performance of HbA1c and fasting plasma glucose in screening for diabetes in patients undergoing coronary angiography.
    Wang JS; Lee IT; Lee WJ; Lin SY; Fu CP; Ting CT; Lee WL; Liang KW; Sheu WH
    Diabetes Care; 2013 May; 36(5):1138-40. PubMed ID: 23238660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test.
    Herdzik E; Safranow K; Ciechanowski K
    Acta Diabetol; 2002 Apr; 39(1):15-22. PubMed ID: 12043934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The simultaneous assessment of glycosylated hemoglobin, fasting plasma glucose and oral glucose tolerance test does not improve the detection of type 2 diabetes mellitus in Colombian adults.
    Lopez-Lopez J; Garay J; Wandurraga E; Camacho PA; Higuera-Escalante F; Cohen D; Lopez-Jaramillo P
    PLoS One; 2018; 13(4):e0194446. PubMed ID: 29652881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycated haemoglobin threshold for dysglycaemia screening, and application to metabolic syndrome diagnosis in HIV-infected Africans.
    Nguyen KA; Peer N; de Villiers A; Mukasa B; Matsha TE; Mills EJ; Kengne AP
    PLoS One; 2019; 14(1):e0211483. PubMed ID: 30703147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.
    Woerle HJ; Pimenta WP; Meyer C; Gosmanov NR; Szoke E; Szombathy T; Mitrakou A; Gerich JE
    Arch Intern Med; 2004 Aug 9-23; 164(15):1627-32. PubMed ID: 15302632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemoglobin A1c levels in a diabetes detection program.
    Santiago JV; Davis JE; Fisher F
    J Clin Endocrinol Metab; 1978 Sep; 47(3):578-80. PubMed ID: 263311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma glucose and hemoglobin A1c for the detection of diabetes in Chinese adults.
    Xu Y; Zhao W; Wang W; Bi Y; Li J; Mi S; Xu M; Lu J; Wang T; Li M; Wang Z; Jiang Y; Wang L; Wang L; Dai M; Zhang D; Lai S; Ning G;
    J Diabetes; 2016 May; 8(3):378-86. PubMed ID: 25940519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation should undergo screening for diabetes by oral glucose tolerance tests.
    Wei C; Unsworth R; Davis N; Cox R; Bradley K; Stevens M; Crowne E
    Diabet Med; 2016 Oct; 33(10):1347-51. PubMed ID: 26757409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of HbA1c to diagnose diabetes among Japanese children detected by a urine glucose screening program in the Tokyo Metropolitan Area.
    Ogawa E; Urakami T; Suzuki J; Yoshida A; Takahashi S; Mugishima H
    Endocr J; 2012; 59(6):465-71. PubMed ID: 22447145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence-a population-based survey of 6898 Han participants from southern China.
    Huang H; Peng G; Lin M; Zhang K; Wang Y; Yang Y; Zuo Z; Chen R; Wang J
    Prev Med; 2013 Oct; 57(4):345-50. PubMed ID: 23777673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.
    Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R
    Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test.
    Alqahtani N; Khan WA; Alhumaidi MH; Ahmed YA
    Int J Prev Med; 2013 Sep; 4(9):1025-9. PubMed ID: 24130943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insufficient sensitivity of hemoglobin A(₁C) determination in diagnosis or screening of early diabetic states.
    Fajans SS; Herman WH; Oral EA
    Metabolism; 2011 Jan; 60(1):86-91. PubMed ID: 20723948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria.
    Tutuncu Y; Satman I; Celik S; Dinccag N; Karsidag K; Telci A; Genc S; Issever H; Tuomilehto J; Omer B
    J Diabetes Res; 2016; 2016():5827041. PubMed ID: 26824043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of fasting plasma glucose and haemoglobin A1c point-of-care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting.
    Mayega RW; Guwatudde D; Makumbi FE; Nakwagala FN; Peterson S; Tomson G; Ostenson CG
    Diabetes Res Clin Pract; 2014 Apr; 104(1):112-20. PubMed ID: 24456993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The usefulness of glycated hemoglobin A1c (HbA1c) for identifying dysglycemic states in individuals without previously diagnosed diabetes.
    Adamska E; Waszczeniuk M; Gościk J; Golonko A; Wilk J; Pliszka J; Maliszewska K; Lipińska D; Milewski R; Wasilewska A; Citko A; Nikołajuk A; Ostrowska L; Krętowski A; Górska M
    Adv Med Sci; 2012; 57(2):296-301. PubMed ID: 22968341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined use of fasting plasma glucose and glycated hemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus.
    Nakagami T; Tominaga M; Nishimura R; Daimon M; Oizumi T; Yoshiike N; Tajima N
    Tohoku J Exp Med; 2007 Sep; 213(1):25-32. PubMed ID: 17785950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.